Clinical trial / 2013
Vitamin C added to fluoxetine reduced depressive symptoms in pediatric major depressive disorder.
In a six-month randomized controlled pilot trial, 24 pediatric patients with major depressive disorder received fluoxetine alongside either 1,000 mg daily of vitamin C or placebo. Adjunctive vitamin C led to significantly greater reductions in depressive symptoms on the Children's Depression Rating Scale (P<0.0001) and Children's Depression Inventory (P<0.0001). Clinical Global Impression scores did not differ between arms.
- Study type
- Randomized controlled trial
- Who was studied
- 24 pediatric patients with major depressive disorder
- What was measured
- Depression rating scale scores (CDRS, CDI, CGI)
THE PAPER
Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
Amr M, El-Mogy A, Shams T, Vieira K, Lakhan SE. Nutr J, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.